LivaNova has been granted a patent for a programmer that collects data from an implantable pulse generator during neurostimulation, displays timing indications, and adjusts stimulation parameters. The device ensures accurate synchronization between the programmer and the pulse generator for effective stimulation titration. GlobalData’s report on LivaNova gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on LivaNova, Wearable defibrillators was a key innovation area identified from patents. LivaNova's grant share as of May 2024 was 49%. Grant share is based on the ratio of number of grants to total number of patents.
Programmer for adjusting neurostimulation parameters during stimulation titration process
A recently granted patent (Publication Number: US11998747B2) outlines a programmer designed to communicate with an implantable pulse generator for neurostimulation purposes. The programmer includes communication circuitry, a user interface, a processor, and memory with instructions for collecting data from the pulse generator during neurostimulation, displaying timing indications of stimulation bursts with a time delay to match actual application, and adjusting stimulation parameters during the process. The programmer can show countdown times for subsequent bursts, therapy status indications, and real-time display of collected data, enhancing the precision and control of neurostimulation therapy.
Moreover, the patent describes a method for delivering neurostimulation to patients using the programmer and pulse generator system. This method involves collecting ongoing neurostimulation data, displaying timing indications synchronized with actual stimulation bursts, and adjusting stimulation parameters during titration. The method includes features like countdown times for future bursts, therapy status indications, and the ability to query and receive timing data blocks from the pulse generator for continued display post-communication. This innovative system aims to optimize the delivery of neurostimulation therapy by ensuring accurate timing and parameter adjustments, potentially improving patient outcomes and treatment efficacy in neurostimulation applications.
To know more about GlobalData’s detailed insights on LivaNova, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
